Ali Parsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Parsa has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Mark R. Nazal
Department of Orthopaedic Surgery, University of Kentucky, Lexington, Kentucky
5 shared publications Scott D. Martin
Sports Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA (Dr. Parsa, Mr. Nazal, Dr. Molenaars, Agrawal, and Dr. Martin), and Orthopaedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran (Dr. Parsa)
5 shared publications- Benjamin Gilbert Domb
American Hip Institute Research Foundation, Chicago, IL 60018; American Hip Institute, Chicago, IL 60018
4 shared publications Maryam Mirzaie
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
4 shared publicationsJavad Parvizi
International Joint Center, Acibadem University Hospital, Istanbul, Turkey
3 shared publicationsMohammad Ghorbani
Orthopedic Research Center, Mashhad University of Medical Sciences , Mashhad
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Vol. 14 (1) , 1-2
Are We Training Surgeons or Supervisors? Artificial Intelligence, Automation, and the Future of Surgical Expertise in Orthopedics.
- 1 January 2026
- Vol. 14 (1) , 1-2
Open AccessAre We Training Surgeons or Supervisors? Artificial Intelligence, Automation, and the Future of Surgical Expertise in Orthopedics.
- Open Access
- 12 June 2025
- Published by Oxford University Press (OUP) in Journal of Hip Preservation Surgery
- Vol. 13 (1) , 56-59
Innovative modified light bulb technique with custom offset curettes for treating precollapsed femoral head osteonecrosis
Osteonecrosis of the femoral head is a devastating disease that accounts for 10–15% of all hip arthroplasty cases in the USA, eventually leading to femoral head collapse and joint destruction. Even the current forms of treatment only slightly slow down the progression of the disease itself. This article describes a modified lightbulb technique, which perfects the method, the instrument, and the flap used in order to ensure hip musculature preservation and improved outcomes. With the direct anterior approach, there is no need to perform surgical dislocation, so the time of the surgery is reduced, as well as the risk of vascular injury. The necrotic bone can be precisely removed using custom-made offset curettes, and a bone graft substitute and autograft can be placed under C-arm guidance. This technique may be beneficial in treating early osteonecrosis of the femoral head by reducing operative time and reducing the risk of complications related to surgical dislocation.
- 12 June 2025
- Published by Oxford University Press (OUP) in Journal of Hip Preservation Surgery
- Vol. 13 (1) , 56-59
Open AccessInnovative modified light bulb technique with custom offset curettes for treating precollapsed femoral head osteonecrosis
Osteonecrosis of the femoral head is a devastating disease that accounts for 10–15% of all hip arthroplasty cases in the USA, eventually leading to femoral head collapse and joint destruction. Even the current forms of treatment only slightly slow down the progression of the disease itself. This article describes a modified lightbulb technique, which perfects the method, the instrument, and the flap used in order to ensure hip musculature preservation and improved outcomes. With the direct anterior approach, there is no need to perform surgical dislocation, so the time of the surgery is reduced, as well as the risk of vascular injury. The necrotic bone can be precisely removed using custom-made offset curettes, and a bone graft substitute and autograft can be placed under C-arm guidance. This technique may be beneficial in treating early osteonecrosis of the femoral head by reducing operative time and reducing the risk of complications related to surgical dislocation.
- 25 February 2025
- Published by Wiley in Arthroscopy
- Vol. 41 (10) , 4303
Posterior Pelvic Tilt Allows for Increased Hip Motion, While Anterior Pelvic Tilt Decreases Joint Stress: A Systematic Review of Biomechanical and Motion Analyses
Purpose: The purpose of this systematic review was to evaluate the effect of pelvic tilt on hip joint contact forces and range of motion in patients with femoroacetabular impingement (FAI) and acetabular dysplasia. Methods: A literature review querying the U.S. National Library of Medicine (PubMed/MEDLINE), EMBASE, SCOPUS, and Cochrane Databases using the key words (“Femoroacetabular Impingement” OR “Hip Dysplasia”) AND (((((“Pelvic Tilt”) OR (Joint Contact) OR (Kinetics) OR (“Pelvic Incidence”) OR (Lumbar Lordosis)))). 14 studies were included in the review with methodological quality evaluated through the Methodological Index for Non‐Randomized Studies (MINORS) and Risk of Bias in Non‐Randomized Studies— of Interventions (ROBINS‐I) criteria. Results: There were 474 total patients (577 hips) in the 14 studies reviewed. Two studies focused on hip joint contact forces and femoral head coverage in acetabular dysplasia. These found that posterior pelvic tilt was associated with decreased hip joint contact area (range: 490–581 mm 2 vs 919–1094 mm 2 ), increased joint contact pressure (range: 3.9–7.3 mPa vs 1.8–3.5 mPa), and decreased femoral head coverage (range: 30.2–43.4% vs 38.9–50.3%) in dysplastic subjects compared to control populations. Twelve studies evaluated the range of hip motion in FAI populations undergoing different functional maneuvers. Posterior pelvic tilt in FAI patients was found to increase hip range of motion to impingement on supine testing and biomechanical modeling (Internal rotation in flexion range: −6.5° to 15.5° with anterior tilt, 12.9° to 31.4° with posterior tilt). With dynamic maneuvers, FAI patients had decreased pelvic mobility (range: 7.2°–14.7° vs 12.7°–24.2°) and decreased posterior pelvic tilt (range: 3.4°–15.9° vs 9.8°−21.1°) compared to patients without FAI. Conclusions: Hip joint stress is increased with posterior pelvic tilt in dysplastic patients, while increasing posterior pelvic tilt increases hip range of motion to impingement in patients with FAI. During weight‐bearing exercises, the ability for FAI patients to posteriorly tilt the pelvis is restricted compared to a control population. Clinical Relevance: Spinopelvic kinematics and alignment affect composite hip motion and play a critical role in bipedal locomotion. The influence of spinopelvic parameters on treatment outcomes for acetabular dysplasia and FAI is controversial and currently limited by an imperfect understanding of the hip‐spine relationship as it relates to nonarthritic hip disease. The present systematic review provides a summary of the results of biomechanical studies investigating pelvic tilt in this population.
- 25 February 2025
- Published by Wiley in Arthroscopy
- Vol. 41 (10) , 4303
Posterior Pelvic Tilt Allows for Increased Hip Motion, While Anterior Pelvic Tilt Decreases Joint Stress: A Systematic Review of Biomechanical and Motion Analyses
Purpose: The purpose of this systematic review was to evaluate the effect of pelvic tilt on hip joint contact forces and range of motion in patients with femoroacetabular impingement (FAI) and acetabular dysplasia. Methods: A literature review querying the U.S. National Library of Medicine (PubMed/MEDLINE), EMBASE, SCOPUS, and Cochrane Databases using the key words (“Femoroacetabular Impingement” OR “Hip Dysplasia”) AND (((((“Pelvic Tilt”) OR (Joint Contact) OR (Kinetics) OR (“Pelvic Incidence”) OR (Lumbar Lordosis)))). 14 studies were included in the review with methodological quality evaluated through the Methodological Index for Non‐Randomized Studies (MINORS) and Risk of Bias in Non‐Randomized Studies— of Interventions (ROBINS‐I) criteria. Results: There were 474 total patients (577 hips) in the 14 studies reviewed. Two studies focused on hip joint contact forces and femoral head coverage in acetabular dysplasia. These found that posterior pelvic tilt was associated with decreased hip joint contact area (range: 490–581 mm 2 vs 919–1094 mm 2 ), increased joint contact pressure (range: 3.9–7.3 mPa vs 1.8–3.5 mPa), and decreased femoral head coverage (range: 30.2–43.4% vs 38.9–50.3%) in dysplastic subjects compared to control populations. Twelve studies evaluated the range of hip motion in FAI populations undergoing different functional maneuvers. Posterior pelvic tilt in FAI patients was found to increase hip range of motion to impingement on supine testing and biomechanical modeling (Internal rotation in flexion range: −6.5° to 15.5° with anterior tilt, 12.9° to 31.4° with posterior tilt). With dynamic maneuvers, FAI patients had decreased pelvic mobility (range: 7.2°–14.7° vs 12.7°–24.2°) and decreased posterior pelvic tilt (range: 3.4°–15.9° vs 9.8°−21.1°) compared to patients without FAI. Conclusions: Hip joint stress is increased with posterior pelvic tilt in dysplastic patients, while increasing posterior pelvic tilt increases hip range of motion to impingement in patients with FAI. During weight‐bearing exercises, the ability for FAI patients to posteriorly tilt the pelvis is restricted compared to a control population. Clinical Relevance: Spinopelvic kinematics and alignment affect composite hip motion and play a critical role in bipedal locomotion. The influence of spinopelvic parameters on treatment outcomes for acetabular dysplasia and FAI is controversial and currently limited by an imperfect understanding of the hip‐spine relationship as it relates to nonarthritic hip disease. The present systematic review provides a summary of the results of biomechanical studies investigating pelvic tilt in this population.
- 9 November 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (2) , S8-S9
Is Aspirin an Effective Prophylaxis Against Venous Thromboembolism in Patients Undergoing Routine Total Knee or Total Hip Arthroplasty?
- 9 November 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (2) , S8-S9
Is Aspirin an Effective Prophylaxis Against Venous Thromboembolism in Patients Undergoing Routine Total Knee or Total Hip Arthroplasty?
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 8 (11)
Comments on “Readability Analysis of Patient Education Material on Rotator Cuff Injuries From the Top 25 Ranking Orthopedic Institutions”
- 1 November 2024
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 8 (11)
Open AccessComments on “Readability Analysis of Patient Education Material on Rotator Cuff Injuries From the Top 25 Ranking Orthopedic Institutions”
- 30 October 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (2) , S154-S155
What Are the Indications for Surgical Intervention for Patients Who Have Femoro-acetabular Impingement of the Hip?
- 30 October 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (2) , S154-S155
What Are the Indications for Surgical Intervention for Patients Who Have Femoro-acetabular Impingement of the Hip?
- 21 October 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 62, 112-121
The efficacy of tranexamic acid in perioperative bleeding following total hip arthroplasty through different surgical approaches: Systematic review and meta-analysis
- 21 October 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 62, 112-121
The efficacy of tranexamic acid in perioperative bleeding following total hip arthroplasty through different surgical approaches: Systematic review and meta-analysis
- 26 January 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 50, 170-176
Slightly reduced early subsidence with similar outcomes and complications rate in collared stems - A systematic review of randomized clinical trials
- 26 January 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 50, 170-176
Slightly reduced early subsidence with similar outcomes and complications rate in collared stems - A systematic review of randomized clinical trials
- 1 December 2023
- Vol. 11 (12) , 731-737
Screening for Femoral Head Osteonecrosis Following COVID-19: Is It Worth It?
Objectives: Based on WHO data, as of June 2022, there were 532.2 million confirmed COVID-19 cases globally. In the initial phase of the COVID -19 pandemic, patients experiencing critical illness marked by severe respiratory distress were commonly subjected to corticosteroid treatment. Regrettably, the administration of exogenous corticosteroids stands as the prevailing cause of ONFH. In the current narrative review, we aim to evaluate if active screening should be utilized to diagnose post-COVID-19 ONFH in its early stages. Methods: The databases for PubMed, CINAHL, and Science Direct were systematically queried in March 2022. The search terms were as follows: "COVID-19", "severe acute respiratory syndrome", "coronavirus", "systemic steroid", "corticosteroid", "femoral head osteonecrosis", "avascular necrosis", or "steroid therapy." The included studies for review were all required to be peer-reviewed studies in the English language with Reported complications linked to steroid therapy in COVID-19 patients or potential connections to the development of ONFH in individuals recovering from the novel coronavirus have been documented. Results: Systemic corticosteroids were frequently employed in managing critically ill COVID-19 patients. The CDC reports up to June 2022 showed more than 4.8 million COVID-19 hospitalizations in the US, with approximately over one million patients receiving steroids. In a study of ONFH after infection with COVID-19, all patients had bilateral involvement. The average duration from the initiation of corticosteroid treatment to the onset of symptoms was 132.8 days. Conclusion: In summary, a distinct correlation exists between the administration of steroids to individuals with COVID19 and the subsequent risk of ONFH. Moreover, an elevated dosage and prolonged duration of steroid therapy in COVID-19 patients are associated with an increased likelihood of developing ONFH. Therefore, active screening for high-risk patients, that may have received systemic corticosteroid treatment during a COVID-19 illness, may be reasonable.
- 1 December 2023
- Vol. 11 (12) , 731-737
Screening for Femoral Head Osteonecrosis Following COVID-19: Is It Worth It?
Objectives: Based on WHO data, as of June 2022, there were 532.2 million confirmed COVID-19 cases globally. In the initial phase of the COVID -19 pandemic, patients experiencing critical illness marked by severe respiratory distress were commonly subjected to corticosteroid treatment. Regrettably, the administration of exogenous corticosteroids stands as the prevailing cause of ONFH. In the current narrative review, we aim to evaluate if active screening should be utilized to diagnose post-COVID-19 ONFH in its early stages. Methods: The databases for PubMed, CINAHL, and Science Direct were systematically queried in March 2022. The search terms were as follows: "COVID-19", "severe acute respiratory syndrome", "coronavirus", "systemic steroid", "corticosteroid", "femoral head osteonecrosis", "avascular necrosis", or "steroid therapy." The included studies for review were all required to be peer-reviewed studies in the English language with Reported complications linked to steroid therapy in COVID-19 patients or potential connections to the development of ONFH in individuals recovering from the novel coronavirus have been documented. Results: Systemic corticosteroids were frequently employed in managing critically ill COVID-19 patients. The CDC reports up to June 2022 showed more than 4.8 million COVID-19 hospitalizations in the US, with approximately over one million patients receiving steroids. In a study of ONFH after infection with COVID-19, all patients had bilateral involvement. The average duration from the initiation of corticosteroid treatment to the onset of symptoms was 132.8 days. Conclusion: In summary, a distinct correlation exists between the administration of steroids to individuals with COVID19 and the subsequent risk of ONFH. Moreover, an elevated dosage and prolonged duration of steroid therapy in COVID-19 patients are associated with an increased likelihood of developing ONFH. Therefore, active screening for high-risk patients, that may have received systemic corticosteroid treatment during a COVID-19 illness, may be reasonable.